Variant report
Variant | nsv159827 |
---|---|
Chromosome Location | chr1:172808445-172809768 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:172809608..172812514-chr1:172814768..172817076,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184351080 | chr1:172808497-172808498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550539848 | chr1:172808513-172808514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571859475 | chr1:172808570-172808571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189103854 | chr1:172808602-172808603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181877374 | chr1:172808656-172808657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs56758569 | chr1:172808780-172808781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6695422 | chr1:172808808-172808809 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs139450814 | chr1:172808821-172808822 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77976189 | chr1:172808825-172808826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146000531 | chr1:172808826-172808827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs6662018 | chr1:172808851-172808852 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs139901548 | chr1:172808857-172808858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558828610 | chr1:172808884-172808885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576956504 | chr1:172808943-172808944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540850510 | chr1:172808956-172808957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149404403 | chr1:172808957-172808958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113869741 | chr1:172808963-172808964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558989989 | chr1:172808982-172808983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111932176 | chr1:172808989-172808990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200169304 | chr1:172808999-172809000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75719119 | chr1:172809002-172809003 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529739298 | chr1:172809023-172809024 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562398751 | chr1:172809045-172809046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575953928 | chr1:172809054-172809055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186530658 | chr1:172809059-172809060 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541392098 | chr1:172809078-172809079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149699073 | chr1:172809082-172809083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530568980 | chr1:172809089-172809090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550456611 | chr1:172809097-172809098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191295754 | chr1:172809125-172809126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs180738233 | chr1:172809180-172809181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73043855 | chr1:172809272-172809273 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs185165545 | chr1:172809288-172809289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554914077 | chr1:172809289-172809290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190713460 | chr1:172809319-172809320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576320265 | chr1:172809342-172809343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs117721674 | chr1:172809345-172809346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374481542 | chr1:172809363-172809364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs367565983 | chr1:172809378-172809379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558402533 | chr1:172809387-172809388 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116759915 | chr1:172809411-172809412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs148425870 | chr1:172809489-172809490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559260693 | chr1:172809493-172809494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574620608 | chr1:172809584-172809585 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183279116 | chr1:172809598-172809599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142532325 | chr1:172809615-172809616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs75416973 | chr1:172809633-172809634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs564246743 | chr1:172809653-172809654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552221661 | chr1:172809654-172809655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532710991 | chr1:172809694-172809695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 20409316 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:172796000-172813800 | Weak transcription | Small Intestine | intestine |
2 | chr1:172806600-172808800 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
3 | chr1:172806800-172809400 | Enhancers | Primary T helper cells fromperipheralblood | blood |
4 | chr1:172807000-172808800 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
5 | chr1:172808200-172808600 | Enhancers | NHEK | skin |
6 | chr1:172808200-172808800 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
7 | chr1:172808200-172808800 | Enhancers | HMEC | breast |
8 | chr1:172808200-172813600 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
9 | chr1:172808200-172813800 | Weak transcription | Primary T cells from cord blood | blood |
10 | chr1:172808200-172813800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr1:172808200-172814600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr1:172808400-172809400 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
13 | chr1:172808400-172813600 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
14 | chr1:172808400-172813600 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
15 | chr1:172808400-172813800 | Weak transcription | Dnd41 | blood |
16 | chr1:172808800-172810000 | Weak transcription | HMEC | breast |
17 | chr1:172808800-172813600 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
18 | chr1:172808800-172813600 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
19 | chr1:172808800-172813800 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
20 | chr1:172808800-172814400 | Weak transcription | HSMMtube | muscle |
21 | chr1:172809400-172809600 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
22 | chr1:172809600-172813600 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |